XM does not provide services to residents of the United States of America.

C3.ai slumps 15% on weak quarterly subscription revenue



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-C3.ai slumps 15% on weak quarterly subscription revenue</title></head><body>

Updates share move in paragraph 1, market valuation in paragraph 8

By Harshita Mary Varghese

Sept 5 (Reuters) -Shares of C3.ai AI.N, which makes software for enterprise artificial intelligence, slumped nearly 15% on Thursday, as subscription revenue was squeezed by slow conversions of pilot customers.

High interest rates and an uncertain economy have led to cautious spending by enterprises, which have kept a tight leash on costs.

The company reported subscription revenue of $73.5 million for the first quarter, missing LSEG estimates of $79.1 million.

For the company, subscription revenue is comprised primarily of software licenses, Software-as-a-Service offerings, pilots and trials of C3.ai applications or generative AI, and consumption-based pricing for which revenue is recognized over time.

"C3.ai had weakness in subscription revenue which decreased by ~$6.5 million quarter-on-quarter compared with adding ~$9.5 million last quarter and ~$5 million in the same period last year," D.A. Davidson analysts wrote in a note.

Management said it continues to expect pressure on gross margins "due to higher mix of pilots, which carry a greater cost of revenue during the pilot phase of the customer life cycle".

"We also expect short-term pressure on our operating margin due to additional investments we are making in our business, including in our salesforce, research and development, and marketing spend," finance chief Hitesh Lath said in a post-earnings call.

The company, whose shares more than doubled last year, is set to lose more than $400 million from its market valuation of $2.97 billion, if losses hold.

For the reported quarter, the company posted total revenue of $87.2 million, an increase of 21%, beating estimates of $86.9 million.




Reporting by Harshita Mary Varghese in Bengaluru; Editing by Krishna Chandra Eluri

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.